MAIA Biotechnology, Inc. (MAIA) - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by MAIA Biotechnology, Inc. on May 21, 2026. The Company is incorporated in Delaware and its common stock trades on the NYSE American under the symbol "MAIA". As of the record date (March 23, 2026), there were 60,671,491 shares of common stock issued and outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
A quorum was established with 37,547,754 shares present (approximately 61.88% of outstanding shares). Two matters were submitted to a vote:
- Election of Class I Directors: Stockholders re-elected both nominees for three-year terms expiring in 2029.
- Louie Ngar Yee: 16,658,677 votes For; 8,796,832 votes Withheld; 11,375,414 Broker Non-Votes.
- Steven Chaouki: 25,109,811 votes For; 345,698 votes Withheld; 11,375,414 Broker Non-Votes.
- Ratification of Auditors: Stockholders ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Votes For: 37,278,294
- Votes Against: 210,408
- Abstain: 19,052
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. For details on proposals, the filing refers investors to the definitive proxy statement dated April 7, 2026.
Key Facts for Investor Verification
- Verify the full text of the definitive proxy statement (filed April 7, 2026) for detailed background on director nominees and auditor selection.
- Note the significant number of broker non-votes (11,375,414) recorded for the director election, which may indicate shares held in street name where brokers lacked discretionary voting authority.
- Confirm the Company's status as an emerging growth company, as indicated by the checkmark in the filing.
- Review subsequent filings for the Company's actual financial performance, as this 8-K contains no financial data.